Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedMar 22, 2025
DataAggregated Company Financials
Companies9
  • 7D2.2%
  • 3M18.0%
  • 1Y27.3%
  • YTDn/a

The Pharma industry is up 2.2% in the last week, with Novartis up 3.0%. This takes the industry's 12 month performance to a gain of 27%. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 22 Mar 2025CHF 487.4bCHF 121.7bCHF 19.2b29.7x25.4x4x
Mon, 17 Feb 2025CHF 475.3bCHF 122.4bCHF 19.1b22.9x24.9x3.9x
Wed, 15 Jan 2025CHF 438.9bCHF 119.9bCHF 21.5b18.3x20.4x3.7x
Fri, 13 Dec 2024CHF 423.2bCHF 118.2bCHF 21.2b18x20x3.6x
Sun, 10 Nov 2024CHF 439.1bCHF 117.4bCHF 21.0b18.9x20.9x3.7x
Tue, 08 Oct 2024CHF 447.3bCHF 115.1bCHF 19.4b21.2x23.1x3.9x
Thu, 05 Sep 2024CHF 468.2bCHF 114.7bCHF 19.3b22.4x24.3x4.1x
Sat, 03 Aug 2024CHF 458.6bCHF 115.3bCHF 19.5b22.6x23.5x4x
Mon, 01 Jul 2024CHF 434.0bCHF 116.4bCHF 19.8b33.7x21.9x3.7x
Wed, 29 May 2024CHF 406.7bCHF 117.3bCHF 19.9b40.9x20.4x3.5x
Fri, 26 Apr 2024CHF 393.5bCHF 113.5bCHF 20.0b36.6x19.7x3.5x
Sun, 24 Mar 2024CHF 386.2bCHF 111.7bCHF 19.3b37.5x20x3.5x
Tue, 20 Feb 2024CHF 386.3bCHF 110.5bCHF 19.7b24.2x19.6x3.5x
Thu, 18 Jan 2024CHF 416.3bCHF 120.2bCHF 18.8b27.3x22.2x3.5x
Sat, 16 Dec 2023CHF 394.8bCHF 120.6bCHF 18.8b24.6x21x3.3x
Mon, 13 Nov 2023CHF 385.0bCHF 122.6bCHF 19.1b23.4x20.2x3.1x
Wed, 11 Oct 2023CHF 410.2bCHF 121.7bCHF 18.7b26.6x22x3.4x
Fri, 08 Sep 2023CHF 401.9bCHF 112.4bCHF 18.0b47.6x22.3x3.6x
Sun, 06 Aug 2023CHF 409.2bCHF 111.4bCHF 17.9b48.3x22.9x3.7x
Tue, 04 Jul 2023CHF 417.7bCHF 115.1bCHF 18.9b36.5x22.1x3.6x
Thu, 01 Jun 2023CHF 426.7bCHF 116.0bCHF 19.0b37.4x22.5x3.7x
Sat, 29 Apr 2023CHF 429.2bCHF 114.9bCHF 18.8b41.1x22.8x3.7x
Mon, 27 Mar 2023CHF 394.1bCHF 116.0bCHF 19.0b39.9x20.8x3.4x
Wed, 22 Feb 2023CHF 410.1bCHF 116.4bCHF 19.0b28.4x21.5x3.5x
Fri, 20 Jan 2023CHF 435.5bCHF 116.7bCHF 34.4b23.5x12.6x3.7x
Sun, 18 Dec 2022CHF 441.7bCHF 117.6bCHF 34.8b23.1x12.7x3.8x
Tue, 15 Nov 2022CHF 438.6bCHF 118.2bCHF 35.1b23.2x12.5x3.7x
Thu, 13 Oct 2022CHF 443.4bCHF 121.5bCHF 37.4b20.6x11.9x3.7x
Sat, 10 Sep 2022CHF 452.1bCHF 119.5bCHF 36.6b21.6x12.4x3.8x
Mon, 08 Aug 2022CHF 452.8bCHF 119.7bCHF 36.6b21.1x12.4x3.8x
Wed, 06 Jul 2022CHF 448.5bCHF 119.1bCHF 37.5b27.4x11.9x3.8x
Fri, 03 Jun 2022CHF 462.7bCHF 118.9bCHF 37.4b28.8x12.4x3.9x
Sun, 01 May 2022CHF 496.9bCHF 119.3bCHF 37.6b31.4x13.2x4.2x
Tue, 29 Mar 2022CHF 496.4bCHF 117.1bCHF 36.5b33.4x13.6x4.2x
Price to Earnings Ratio

13.6x


Total Market Cap: CHF 496.4bTotal Earnings: CHF 36.5bTotal Revenue: CHF 117.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 19.2x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.4x which is higher than its 3-year average PE of 19.2x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 19% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Swiss Pharma compare with similar industries?

CH Market1.10%
Healthcare2.10%
Pharma2.23%
Pharma2.23%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVN NovartisCHF 99.233.0%
+CHF 5.7b		14.7%PE18.6x
ROG Roche HoldingCHF 309.201.1%
+CHF 2.7b		37.2%PE29.7x
GALD Galderma GroupCHF 97.578.2%
+CHF 1.8b		52.5%PE113.5x
SDZ Sandoz GroupCHF 38.032.6%
+CHF 417.8m		40.9%PS1.8x
COPN Cosmo PharmaceuticalsCHF 56.504.2%
+CHF 36.9m		-14.5%PE13.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NOVN

CHF 99.23

Novartis

7D

3.0%

1Y

14.7%

ROG

CHF 309.20

Roche Holding

7D

1.1%

1Y

37.2%

GALD

CHF 97.57

Galderma Group

7D

8.2%

1Y

52.5%

COPN

CHF 56.50

Cosmo Pharmaceuticals

7D

4.2%

1Y

-14.5%

SDZ

CHF 38.03

Sandoz Group

7D

2.6%

1Y

40.9%

BIOV

CHF 35.30

BioVersys

7D

-1.1%

1Y

n/a

CURN

CHF 10.45

Curatis Holding

7D

-5.0%

1Y

n/a

DESN

CHF 195.00

Dottikon ES Holding

7D

0.1%

1Y

-16.8%

Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

Feb 12
Dottikon ES Holding AG's (VTX:DESN) Business Is Yet to Catch Up With Its Share Price

NWRN

CHF 8.41

Newron Pharmaceuticals

7D

-0.1%

1Y

13.0%

ADXN

CHF 0.057

Addex Therapeutics

7D

1.8%

1Y

-33.3%